B-cell non-hodgkins lymphoma

Clinical trials for B-cell non-hodgkins lymphoma explained in plain language.

Never miss a new study

Get alerted when new B-cell non-hodgkins lymphoma trials appear

Sign up with your email to follow new studies for B-cell non-hodgkins lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New combo aims to tame side effects in Tough-to-Treat lymphoma

Disease control Recruiting now

This study tests a new drug combination (glofitamab plus gemcitabine and oxaliplatin) in about 100 people with aggressive B-cell lymphoma that has returned or not responded to prior therapy. The main goal is to see if a better steroid plan can reduce a serious side effect called …

Matched conditions: B-CELL NON-HODGKINS LYMPHOMA

Phase 2 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Sep 13, 2026 00:00 UTC

B-cell non-hodgkins lymphoma

Get alerted when new B-cell non-hodgkins lymphoma trials appear

New combo aims to tame side effects in Tough-to-Treat lymphoma